Skip to content

A prospective controlled study of early hearing intervention on delayed cognitive impairment in the elderly

A prospective controlled study of early hearing intervention on delayed cognitive impairment in the elderly

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100053396
Enrollment
Unknown
Registered
2021-11-20
Start date
2020-06-01
Completion date
Unknown
Last updated
2022-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Presbycusis, cognitive dysfunction

Interventions

experimental group:with hearing-aid
control group:none

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria for the experimental group: This experiment included binaural sensorineural hearing loss aged 55 years and above (according to the World Health Organization standard, 0.5,1,2,4kHz average value > 25dBHL), if the degree of binaural hearing loss is different, better The degree of ear hearing loss shall prevail). With the naked eye or wearing glasses, you can clearly see fonts of the same size as the Digit Symbol Substition Test (DSST) test. There was no cognitive decline in the DSST test. The hand can hold a pen and write. According to the degree of hearing loss, both ears are fitted with hearing aids suitable for the degree of hearing loss. Inclusion criteria for the control group: binaural sensorineural hearing loss aged 55 years and above (according to the World Health Organization standard, 0.5,1,2,4kHz average value > 25dBHL), if the degree of binaural hearing loss is different, better The degree of ear hearing loss shall prevail). With the naked eye or wearing glasses, you can see fonts of the same size as the DSST test. There was no cognitive decline in the DSST test. The hand can hold a pen and write. He is not wearing a hearing device.

Exclusion criteria

Exclusion criteria: Carrying 3 pathogenic genes of dementia (amyloid precursor gene (APP) of chromosome 21, PSEN1 of chromosome 14 presenilin-1 gene, PSEN2 of chromosome 1 presenilin-2 gene), first-degree relatives (parents, brothers) Sisters) have hospitals diagnosed patients with dementia, MRI showed cerebral hemorrhage, cerebral infarction, cerebrovascular disease, or previous hospitals diagnosed cerebral hemorrhage, cerebral infarction or cerebrovascular disease, abnormal blood pressure (according to the 2019 Chinese Medical Association promulgation Guidelines for the primary diagnosis and treatment of hypertension, hypertension systolic blood pressure >= 140mmHg and/or diastolic blood pressure >= 90mmHg), abnormal blood glucose (according to the position statement issued by the Australian Diabetes Association in 2015, using glycosylated hemoglobin (HbA1c) as a diagnosis of type 2 diabetes is cost-effective and effective , Simple diagnostic tools, HbA1c>6.5% is the diagnostic criteria), abnormal body mass (according to the Body Mass Index (BMI) Chinese reference standard, weight/height 2>24 overweight, BMI= 11 lungs (Moderately affected functions), syphilis, HIV, living alone without social activities, pure tone audiometry is neurological hearing loss, and posterior cochlear hearing loss with normal otoacoustic emission. Binaural or monaural hearing loss is conductive or mixed.

Design outcomes

Primary

MeasureTime frame
Digit Symbol Substitution Test;Mini-Mental State Examination;pure-tone auditory;

Countries

China

Contacts

Public ContactZhaoli Meng
lucy-mengzhaoli@163.com+86 18980606732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026